Cannabinoid type 2 receptor agonist JWH-133, attenuates Okadaic acid induced spatial memory impairment and neurodegeneration in rats
dc.authorid | Tekin, Suat/0000-0002-2757-1802 | |
dc.authorid | Cigremis, Yilmaz/0000-0002-8600-0946 | |
dc.authorid | Cakir, Murat/0000-0002-2066-829X | |
dc.authorid | Sandal, Suleyman/0000-0002-8916-3329 | |
dc.authorid | Erden, Yavuz/0000-0002-2807-6096 | |
dc.authorwosid | Tekin, Suat/KEI-2266-2024 | |
dc.authorwosid | Tekin, Suat/AAG-1440-2021 | |
dc.authorwosid | Cigremis, Yilmaz/O-6019-2015 | |
dc.authorwosid | Cakir, Murat/I-8643-2019 | |
dc.authorwosid | Sandal, Suleyman/AAA-6388-2021 | |
dc.authorwosid | Erden, Yavuz/IZE-2291-2023 | |
dc.authorwosid | Doğanyiğit, Züleyha/AAW-2347-2021 | |
dc.contributor.author | Cakir, Murat | |
dc.contributor.author | Tekin, Suat | |
dc.contributor.author | Doganyigit, Zuleyha | |
dc.contributor.author | Erden, Yavuz | |
dc.contributor.author | Soyturk, Merve | |
dc.contributor.author | Cigremis, Yilmaz | |
dc.contributor.author | Sandal, Suleyman | |
dc.date.accessioned | 2024-08-04T20:45:33Z | |
dc.date.available | 2024-08-04T20:45:33Z | |
dc.date.issued | 2019 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Aim: Cannabinoid system has various physiological roles such as neurogenesis, synaptic plasticity and emotional state regulation in the body. The presence of cannabinoid type 2 receptor (CB2), a member of the cannabinoid system, was detected in different regions of the brain. CB2 receptor plays a role in neuroinflammatory and neurodegenerative processes. We aimed to determine the possible effect of CB2 agonist JWH-133 in Okadaic acid (OKA)-induced neurodegeneration model mimicking Alzheimer's Disease (AD) through tau pathology. Materials and methods: In this study, 40 Sprague Dawley male rats were divided into 4 groups (Control, Sham, OKA, OKA + JWH-133). Bilateral intracerebroventricular (icv) injection of 200 ng OKA was performed in the OKA group. In the OKA + JWH-133 group, injection of JWH-133 (0.2 mg/kg) was performed intraperitoneally for 13 days different from the group of OKA. Morris water maze test was used to evaluate the spatial memory. Levels of caspase-3, phosphorylated tau (ser396), amyloid beta (A beta), tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) levels in brain cortex; and the hippocampus regions were examined by immunohistochemical methods. Key findings: In the OKA group, caspase-3, phosphorylated tau (ser396), A beta, IL-1 beta levels were higher in the cortex and hippocampus than in the other groups. The implementation of the JWH-133 reversed the increments in these parameters, and also prevented spatial memory impairment. | en_US |
dc.description.sponsorship | Department of Scientific Research Projects of Bozok University [6602c-TF/17-139] | en_US |
dc.description.sponsorship | This study was supported by the Department of Scientific Research Projects of Bozok University (Project no: 6602c-TF/17-139). Authors declare no conflict of interest. | en_US |
dc.identifier.doi | 10.1016/j.lfs.2018.11.058 | |
dc.identifier.endpage | 33 | en_US |
dc.identifier.issn | 0024-3205 | |
dc.identifier.issn | 1879-0631 | |
dc.identifier.pmid | 30500552 | en_US |
dc.identifier.scopus | 2-s2.0-85057559841 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 25 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.lfs.2018.11.058 | |
dc.identifier.uri | https://hdl.handle.net/11616/98553 | |
dc.identifier.volume | 217 | en_US |
dc.identifier.wos | WOS:000454622400004 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
dc.relation.ispartof | Life Sciences | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Alzheimer's disease | en_US |
dc.subject | Okadaic acid | en_US |
dc.subject | Cannabinoid type 2 receptor | en_US |
dc.subject | JWH-133 | en_US |
dc.title | Cannabinoid type 2 receptor agonist JWH-133, attenuates Okadaic acid induced spatial memory impairment and neurodegeneration in rats | en_US |
dc.type | Article | en_US |